North Texas Rehabilitation Center
Analysis
North Texas Rehabilitation Center is a registered charity in United States, based in Wichita Falls, TX. It received its IRS tax-exemption ruling in May 1989, 37 years ago. Its declared purposes cover health care, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (gross receipts test) under section 501(c)(3), and contributions to it are listed as tax-deductible.
In the financial year ending August 2023, North Texas Rehabilitation Center reported income of $5.0m and spending of $4.9m, spending 98% of its income. Across the 5 years on record, from August 2019 to August 2023, income grew from $4.8m to $5.0m (+4.9%), an average of +1.2% a year. Over the whole period it spent 99% of the income it received.
Among 40,470 United States charities whose main cause is health and saving lives and that reported income, North Texas Rehabilitation Center sits at the 79th percentile: it is larger than about 79% of them. Against every charity in United States with reported income it ranks in the 92nd percentile, and in the 94th percentile within TX. Charities of a similar size with the same main cause include Seabury at Home Incorporated ($5.0m), Tykes & Teens Inc ($5.0m) and Drug Abuse Alternatives Center ($5.0m).
On its Form 990 for the period ending August 2023, revenue came from contributions and grants 33% and program service revenue 67% of the total. Compensation of current officers, directors and key employees was $3.3m (68% of expenses). At year end it held assets of $3.2m against liabilities of $290k, net assets of $2.9m. It reported 87 employees.
Income and spending
Where the income comes from
- Contributions & grants 33%
- Program services 67%
- Other 0.3%
Similar-sized charities, same cause
| Charity | Location | Income |
|---|---|---|
| Seabury at Home Incorporated | Bloomfield | $5.0m |
| Tykes & Teens Inc | Stuart | $5.0m |
| Drug Abuse Alternatives Center | Santa Rosa | $5.0m |
| Abccm Doctors Medical Clinic Inc | Arden | $5.0m |